Failure to Notify Physician of Resident's Condition Changes
Summary
The facility failed to notify the attending physician and psychiatrist when a resident experienced increased paranoia and refused prescribed medications, including Risperdal and Keppra. The resident expressed delusional beliefs of being poisoned and refused medication multiple times, which was not communicated to the medical professionals as required by the facility's policies. This lack of communication resulted in the resident's physician being unaware of the resident's condition, delaying potential necessary interventions. Additionally, the facility did not notify the physician regarding the resident's last Keppra blood level after the resident experienced a seizure. The resident was later hospitalized, and tests revealed that the Keppra level was below the therapeutic range. This oversight placed the resident at risk for further seizures and associated complications, as the physician was not informed to adjust the treatment plan accordingly. The facility's documentation practices were also deficient, with multiple instances of blank entries in the Medication Administration Record (MAR) for both Keppra and Risperdal, as well as inadequate documentation of seizure monitoring and paranoia episodes. These documentation lapses contributed to the failure to notify the physician of significant changes in the resident's condition, further compromising the resident's care and safety.
Removal Plan
- Medical Director, who was also the R1's Medical Doctor (MD 1) was made aware by the nurses regarding R1's history of refusal of Risperdal and Keppra medication.
- R1 has been taking medications: Keppra and Risperdal.
- There are no refusals noted at this time for all 10 residents receiving Keppra and six residents receiving Risperdal.
- The Director of Nursing Services informed the psychiatrist regarding the history of refusals of prescribed medication: Risperdal for R1.
- The Nurse Health Practitioner 1 (NP 1) was made aware of the R1'S blood Keppra Level and have ordered to have a repeat of blood Keppra Level.
- Keppra level was within normal range of 29.9 microgram/ml; normal range is 6 - 46 ug/ml and made aware MD 1.
- Keppra level was obtained from MD 1 by the ADON to all 10 residents on Keppra medications.
- The NP 1 seen R1 and was agreeable with the plan of care.
- Licensed nurse updated the Care Plan for history of refusal of medication of R1.
- Licensed nurse has informed NP 1 history of R1's refusal of medications and documented in the clinical record of R1.
- There are no refusal noted at this time for all 10 residents receiving Keppra.
- Licensed nurses will initiate change of condition (COC) if resident will have any refusal on medications and will notify the health practitioner. R1 has no episode of further refusal.
- Licensed Nurses were provided in-services by the facility nurse leaders with regards to and not limited to the following: initiating COC for refusal of medications, missed doses, notifying health practitioners of the refusal to medications, monitoring resident's episode of refusal to medications every shift, monitoring of episodes of behaviors such as paranoia and aggressive behaviors. 85% of licensed nurses was provided education by the DON/designee. The facility's nurse leader/designee will continue to provide in-services to all remaining nurses (15%) on their next work schedule. The Director of Staff Developer (DSD) followed up regarding implementation of the in-services and conducted skilled competency training to 85% of licensed nurses (remaining 15% of licensed nurses will be trained on skills competency upon upcoming shifts).
- The Comprehensive and personalized care plan for R1 for fall management is developed and revised by the DON and coordinated to the staff for continuity of care.
- Care plan for fall management is updated by the DON and collaborated with staff for continuity of care and implementation of the plan of care.
- Licensed nurse updated the R1 care plan for seizure management and seizure activity. Nurses will continue to document seizure monitoring in the MAR every shift as ordered.
- All 10 residents on Keppra medication have orders for monitoring for seizure every shift by their primary physicians. The licensed nurses will inform the primary physicians regarding seizure activity and re-education provided by the DON regarding sign and symptoms of seizure.
- Quality Assurance and Performance Improvement (QAPI) meeting was conducted with Medical Director, ADM, DON, Administrative personnel and ADON regarding concerns with IJ: Physician notification, informed consents, COC-episode of refusals, MAR missing documentations and manifested behaviors, seizure and fall management and precautions; the DON will continue to monitor twice a week for four weeks then once a month then quarterly and ensure the audits done in timely manner.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release May 27, 2026) and official state health department websites — never guesswork.
Trusted by long-term care providers and associations.



